On June 10, 2017, Professor Bai Haishan and Dr. Zhang Weizhong won third prize for outstanding clinical research paper in the 17th National Conference on Radioactive Particle Seed Implantation held at Guangzhou Baiyun International Conference Center.
The conference brought together more than 800 renowned international experts from China, the United States, Japan and other countries, including the director of a Tertiary Hospital - Peking University Cancer Hospital; director of radiation therapy department; deputy director of Radiation Oncology Department of Peking University Medical School, Professor Wu Junhong; Director of the Center for Medical Imaging and Intervention of the Affiliated Tumor Hospital of Sun Yat-sen University; Ms. Anuja Jhingran of the MD Anderson Cancer Center in the United States; Japan's renowned minimally invasive expert, Dr. Shiro Saito and so on.
The purpose of this study was to evaluate the use of CT-guided I125 radioactive particles after undergoing painful traditional radiotherapy and chemotherapy. After undergoing CT-guided I125 radioactive particle treatment, there is no bone metastases occurred and moreover, the subject did not suffer from any side effects. The safety and efficacy of the treatment in treating bone metastasis is very significant. A total of 58 patients were enrolled in this study from June 2012 to October 2015, which used digital pain criteria (BPI), visual analog scale (VSA), and analgesic drug use were compared. The score results verify that CT-guided I125 radioactive particles are safer and more effective in the treatment of bone metastases even after undergoing painful traditional radiotherapy and chemotherapy.
St. Stamford Modern Cancer Hospital Guangzhou is a Chinese-Singapore joint venture, international JCI certification hospital that has been promulgating the use of minimally invasive treatment for cancer treatment. Professor Bai Haishan, the director of St. Stamford Modern Cancer Hospital Guangzhou – Minimally Invasive Oncology Specialist has implemented more than 2,000 cases of particle implantation therapy and accumulated wide experiences in this field of study.
Currently, Professor Bai Haishan and Dr. Zhang Weizhong won third prize of outstanding clinical research paper that is entitled: "CT-guided I125 radioactive particles in the case of bone metastases after failure of treatment using radiotherapy and chemotherapy.” This achievement marks the innovative ability of St. Stamford Modern Cancer Hospital Guangzhou in providing minimally invasive treatments to patients worldwide!
Telephone: